NYSE:HLN

Haleon (HLN) Stock Forecast, Price & News

$8.09

-0.06 (-0.74%)

(As of 08:42 AM ET)

Compare

Today's Range: $8.09
▼
$8.09
50-Day Range: $7.85
▼
$8.94
52-Week Range: $5.81
▼
$9.05

Volume: 14,642 shs
Average Volume: 4.13 million shs
Market Capitalization: $37.35 billion

P/E Ratio: N/A
Dividend Yield: 1.11%
Price Target: N/A

Haleon MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
0.27% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.76
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 8.89%
From $0.45 to $0.49 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.06 out of 5 stars

Medical Sector

636th out of 961 stocks

Toilet Preparations Industry

9th out of 11 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Haleon.

5.0

Short Interest

Percentage of Shares Shorted
0.27% of the float of Haleon has been sold short.
Short Interest Ratio / Days to Cover
Haleon has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Haleon has recently decreased by 42.93%, indicating that investor sentiment is improving significantly.

1.7

Dividend Strength

Dividend Yield
Haleon pays a meaningful dividend of 1.13%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Haleon does not have a long track record of dividend growth.
Dividend Sustainability
Based on earnings estimates, Haleon will have a dividend payout ratio of 18.37% next year. This indicates that Haleon will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for HLN.

3.2

News and Social Media Coverage

News Sentiment
Haleon has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Haleon this week, compared to 2 articles on an average week.
MarketBeat Follows
9 people have added Haleon to their MarketBeat watchlist in the last 30 days. This is an increase of 800% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Haleon insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 6.67% of the stock of Haleon is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Haleon are expected to grow by 8.89% in the coming year, from $0.45 to $0.49 per share.
Price to Earnings Growth Ratio
Haleon has a PEG Ratio of 2.77. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Haleon has a P/B Ratio of 1.85. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Haleon (NYSE:HLN) Stock

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.

HLN Price History

30 days | 90 days | 365 days | Advanced Chart

HLN Stock News Headlines

September 23, 2023 | americanbankingnews.com

Haleon plc (NYSE:HLN) Given Consensus Recommendation of "Moderate Buy" by Analysts

September 17, 2023 | americanbankingnews.com

Haleon (NYSE:HLN) Sees Unusually-High Trading Volume

September 25, 2023 | Wall Street Fundamentals (Ad)

Would Buffett Approve of This Growth Strategy?

Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.

August 24, 2023 | finance.yahoo.com

Haleon plc: Recent weakness provides buying opportunity

August 2, 2023 | seekingalpha.com

Haleon plc 2023 Q2 - Results - Earnings Call Presentation

July 26, 2023 | reuters.com

GSK raises 2023 outlook boosted by vaccine, HIV drug sales

July 17, 2023 | finance.yahoo.com

Returns Are Gaining Momentum At Haleon (LON:HLN)

July 14, 2023 | proactiveinvestors.com

Haleon reportedly plans sweeping jobs cuts

September 25, 2023 | Wall Street Fundamentals (Ad)

Would Buffett Approve of This Growth Strategy?

July 12, 2023 | msn.com

A Look Into Haleon Inc's Price Over Earnings

June 29, 2023 | seekingalpha.com

Haleon: Leading Business In An Attractive Industry

June 11, 2023 | seekingalpha.com

Haleon: A Hidden Gem In The Consumer Health Market

June 2, 2023 | finance.yahoo.com

Does The Market Have A Low Tolerance For Haleon plc's (LON:HLN) Mixed Fundamentals?

May 24, 2023 | wsj.com

Haleon PLC

May 12, 2023 | msn.com

GSK cuts its Haelon stake in $1B share sale

May 5, 2023 | seekingalpha.com

Haleon: Brand Portfolio Strength Keeps Us Bullish

April 19, 2023 | proactiveinvestors.com

Haleon profit margin may disappoint, says Barclays

February 6, 2023 | finance.yahoo.com

Haleon plc's (LON:HLN) largest shareholders are public companies with 45% ownership, institutions own 42%

January 19, 2023 | finance.yahoo.com

Is This the Time to Add Haleon plc (HLN) to Your Portfolio?

November 16, 2022 | insidermonkey.com

Ken Fisher Strategy: 5 New Stock Picks

November 13, 2022 | finance.yahoo.com

Haleon Reports Third Quarter 2022 Earnings

November 9, 2022 | finance.yahoo.com

Should You Invest in Haleon plc (HLN)?

October 19, 2022 | finance.yahoo.com

An Intrinsic Calculation For Haleon plc (LON:HLN) Suggests It's 34% Undervalued

October 18, 2022 | barrons.com

Johnson & Johnson Earnings Top Estimates. Its CFO Explains What Went Right. - Barron's

October 13, 2022 | uk.finance.yahoo.com

Is the Haleon share price cheap under £3 ahead of earnings? - Yahoo Finance UK

October 11, 2022 | proactiveinvestors.com

Haleon PLC sales targets impress Barclays - Proactive Investors USA

October 4, 2022 | investing.com

The Bullish Case For GlaxoSmithKline At Current Levels - Investing.com

See More Headlines

Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

HLN Company Calendar

Last Earnings: 8/02/2023
Ex-Dividend for 10/5 Dividend: 8/24/2023
Today: 9/24/2023
Dividend Payable: 10/05/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Toilet preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:HLN
CUSIP: N/A
CIK: 1900304
Web: www.haleon.com
Phone: 44-19-3282-2000
Fax: N/A
Employees: 24,622
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: 18.11
P/E Growth: 2.77
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 0.53
Current Ratio: 0.84
Quick Ratio: 0.54

Sales & Book Value

Annual Sales: $13.43 billion
Price / Sales: 2.80
Cash Flow: $0.36 per share
Price / Cash Flow: 22.59
Book Value: $4.41 per share
Price / Book: 1.85

Miscellaneous

Outstanding Shares: 4,617,290,000
Free Float: N/A
Market Cap: $37.63 billion
Optionable: Not Optionable
Beta: 0.29

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Brian McNamara (Age 56)
CEO & Exec. Director
Comp: $2.94M

Mr. Tobias Hestler (Age 50)
CFO & Exec. Director
Comp: $1.25M

Ms. Amy Landucci
Chief Digital & Technology Officer

Mr. Bjarne Philip Tellmann (Age 56)
Gen. Counsel

Ms. Tamara Rogers (Age 53)
Chief Marketing Officer

Ms. Mairead Nayager (Age 48)
Chief HR Officer

Mr. Bart Derde (Age 53)
Chief Supply Chain Officer

Mr. Filippo Lanzi
Pres of EMEA & LatAm

Ms. Teri Lyng (Age 60)
Head of Transformation & Sustainability

Ms. Jooyong Lee (Age 45)
Head of Strategy & Office of the CEO

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

HLN Stock - Frequently Asked Questions

Should I buy or sell Haleon stock right now?: 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HLN shares.
View HLN analyst ratings or view top-rated stocks.
How have HLN shares performed in 2023?: Haleon's stock was trading at $8.00 at the start of the year. Since then, HLN stock has increased by 1.9% and is now trading at $8.15.
View the best growth stocks for 2023 here.
Are investors shorting Haleon?: Haleon saw a decrease in short interest in August. As of August 31st, there was short interest totaling 12,630,000 shares, a decrease of 42.9% from the August 15th total of 22,130,000 shares. Based on an average daily trading volume, of 3,570,000 shares, the days-to-cover ratio is currently 3.5 days. Approximately 0.3% of the shares of the stock are sold short.
View Haleon's Short Interest.
How were Haleon's earnings last quarter?: Haleon plc (NYSE:HLN) posted its earnings results on Wednesday, August, 2nd. The company reported $0.08 earnings per share (EPS) for the quarter. The company had revenue of $3.44 billion for the quarter.
How often does Haleon pay dividends? What is the dividend yield for Haleon?: Haleon announced a -- dividend on Wednesday, August 2nd. Stockholders of record on Friday, August 25th will be given a dividend of $0.046 per share on Thursday, October 5th. This represents a dividend yield of 1.3%. The ex-dividend date of this dividend is Thursday, August 24th.
Read our dividend analysis for HLN.
What ETFs hold Haleon's stock?: ETFs with the largest weight of Haleon (NYSE:HLN) stock in their portfolio include VanEck Pharmaceutical ETF (PPH), Pacer BioThreat Strategy ETF (VIRS), ClearBridge Focus Value ESG ETF (CFCV), Horizon Kinetics Medical ETF (MEDX),

Is Haleon a good dividend stock?: Haleon (NYSE:HLN) pays an annual dividend of $0.09 per share and currently has a dividend yield of 1.13%.
Read our dividend analysis for HLN.
What is Haleon's stock symbol?: Haleon trades on the New York Stock Exchange (NYSE) under the ticker symbol "HLN."
Who are Haleon's major shareholders?: Haleon's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Clearbridge Investments LLC (0.55%), Fisher Asset Management LLC (0.37%), Harding Loevner LP (0.29%), Alliancebernstein L.P. (0.25%), Douglas Lane & Associates LLC (0.15%) and State Street Corp (0.14%).
How do I buy shares of Haleon?: Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Haleon's stock price today?: One share of HLN stock can currently be purchased for approximately $8.15.
How much money does Haleon make?: Haleon (NYSE:HLN) has a market capitalization of $37.63 billion and generates $13.43 billion in revenue each year.
How many employees does Haleon have?: The company employs 24,622 workers across the globe.
How can I contact Haleon?: The official website for the company is www.haleon.com. The company can be reached via phone at 44-19-3282-2000 or via email at investor-relations@haleon.com.

This page (NYSE:HLN) was last updated on 9/25/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial